Interaction between 038R and 125R of Cherax quadricarinatus iridovirus (CQIV) and their effects on virus replication

Decapod iridescent virus 1 (DIV1) 168L can target cuticle protein 8 from Litopenaeus vannamei

Decapod iridescent virus 1 (DIV1) stands as a significant pathogen affecting crustaceans, posing a grave threat to the shrimp industries in aquaculture dependent nations. Within the Iridoviridae family, the conserved envelope protein DIV1-168L plays a pivotal role in virion entry. Nonetheless, the host factors that interact with 168L remain unidentified. To address this gap, we established a cDNA library derived from Litopenaeus vannamei gill tissue and conducted yeast two-hybrid screening to identify host factors that interact with 168L. Additionally, we performed co-immunoprecipitation assays to verify the interaction between cuticle protein 8 (CP8) and 168L. Expression pattern analysis revealed the presence of CP8 transcripts in the gill and epidermis. Furthermore, immunohistochemistry results demonstrated the expression of CP8 in gill cells and its localization in the gill filament epithelium. Fluorescence analysis indicated that full-length CP8 colocalized with 168L in the cytoplasm of Sf9 cells. Removal of the signal peptide from the N-terminal of CP8 eliminated its concentration in the cytoplasm. Additionally, CP8 expression was significantly inhibited during DIV1 infection. Therefore, our research contributes to a better understanding of the entry mechanism of iridovirids. The GenBank accession number for the DIV1 sequence is MF197913.1.

Identification and characterization of an envelope protein 168L in Cherax quadricarinatus iridovirus (CQIV)

Cherax quadricarinatus iridovirus (CQIV), a new member of family Iridoviridae, mainly infects the shrimps and crayfish with a high mortality rate. Previous gel-based LC-MS/MS study on CQIV has identified 30 structural proteins. In this study, one of the structural proteins, CQIV-168L, was selected for further analysis. RT-PCR and Western-blotting (WB) detection revealed that the transcript and the protein appeared late during infection of C. quadricarinatus cells and that the transcript was blocked by viral DNA replication inhibitor, indicating that CQIV-168L is a late expression gene. The specific antiserum against CQIV-168L was raised and immunofluorescence analysis showed that CQIV-168L was localized in the cytoplasm and associated with virus factories. Western-blotting (WB) assay suggested that CQIV-168L antiserum bound specifically to a 57-kDa protein in both the intact virions and the envelope fraction. As revealed by immunogold labeling, CQIV-168L was a component of the viral envelope. Findings in this work help to further understand the structure and entry mechanism of CQIV.